Skip to main content

Advertisement

SpringerLink
Log in

Persisting fatigue in Hodgkin lymphoma survivors: a systematic review

  • Review Article
  • Published:
Annals of Hematology Aims and scope Submit manuscript

Abstract

Hodgkin Lymphoma (HL) survivors are at risk for adverse psychosocial events as a result from cancer diagnosis and treatment. Fatigue is one of the most frequently reported long-term symptoms and is often reported to interfere with daily life. We conducted a systematic review to determine prevalence, severity and predisposing factors of fatigue in HL survivors. A literature search was conducted up to August 2012. Twenty-two articles comparing HL survivors with norm population data met all predefined selection criteria. Prevalence rates, levels of fatigue and clinical relevance of the results were determined. Prevalence of fatigue ranged from 11–76 % in HL survivors compared to 10 % in the general population. Mean fatigue scores were 5–13 % higher compared to the normative population; these findings were clinically relevant in 7 out of 11 studies. Increasing age was associated with higher levels of fatigue in HL survivors. Treatment modality and stage of initial disease were not associated with higher fatigue levels, while comorbidities or other treatment sequelae seemed to impact on the levels of fatigue. HL survivors are at serious risk for developing clinically relevant, long-term fatigue. The impact of patient and treatment characteristics on risk of fatigue is limited. Focus for future research should shift to the role of late-treatment sequelae and psychological distress symptoms.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. De Bruin ML, Sparidans J, Van’t Veer MB et al (2009) Breast cancer risk in female survivors of Hodgkin’s lymphoma: lower risk after smaller radiation volumes. J Clin Oncol 27:4239–4246

    Article  PubMed  Google Scholar 

  2. van den Belt-Dusebout AW, Aleman BM, Besseling G et al (2009) Roles of radiation dose and chemotherapy in the etiology of stomach cancer as a second malignancy. Int J Radiat Oncol Biol Phys 75:1420–1429

    Article  PubMed  Google Scholar 

  3. Aleman BM, van den Belt-Dusebout AW, Klokman WJ et al (2003) Long-term cause-specific mortality of patients treated for Hodgkin’s disease. J Clin Oncol 21:3431–3439

    Article  PubMed  Google Scholar 

  4. van den Belt-Dusebout AW, De WR, Gietema JA et al (2007) Treatment-specific risks of second malignancies and cardiovascular disease in 5-year survivors of testicular cancer. J Clin Oncol 25:4370–4378

    Article  PubMed  Google Scholar 

  5. Fobair P, Hoppe RT, Bloom J et al (1986) Psychosocial problems among survivors of Hodgkin’s disease. J Clin Oncol 4:805–814

    PubMed  CAS  Google Scholar 

  6. Flechtner H, Ruffer JU, Henry-Amar M et al (1998) Quality of life assessment in Hodgkin’s disease: a new comprehensive approach. First experiences from the EORTC/GELA and GHSG trials. EORTC Lymphoma Cooperative Group. Groupe D’Etude des Lymphomes de L’Adulte and German Hodgkin Study Group. Ann Oncol 9(Suppl 5):147–154

    Article  Google Scholar 

  7. Ganz PA, Moinpour CM, Pauler DK et al (2003) Health status and quality of life in patients with early-stage Hodgkin’s disease treated on Southwest Oncology Group study 9133. J Clin Oncol 21:3512–3519

    Article  PubMed  Google Scholar 

  8. Bloom JR, Fobair P, Gritz E et al (1993) Psychosocial outcomes of cancer: a comparative analysis of Hodgkin’s disease and testicular cancer. J Clin Oncol 11:979–988

    PubMed  CAS  Google Scholar 

  9. Stasi R, Abriani L, Beccaglia P et al (2003) Cancer-related fatigue: evolving concepts in evaluation and treatment. Cancer 98:1786–1801

    Article  PubMed  Google Scholar 

  10. Ganz PA, Bower JE (2007) Cancer related fatigue: a focus on breast cancer and Hodgkin’s disease survivors. Acta Oncologica 46:474–479

    Article  PubMed  Google Scholar 

  11. Arden-Close E, Pacey A, Eiser C (2010) Health-related quality of life in survivors of lymphoma: a systematic review and methodological critique. Leuk Lymphoma 51:628–640

    Article  PubMed  Google Scholar 

  12. Roper K, McDermott K, Cooley ME et al (2009) Health-related quality of life in adults with Hodgkin’s disease: the state of the science. Cancer Nurs 32:E1–E17

    Article  PubMed  Google Scholar 

  13. Henry-Amar M, Joly F (1996) Late complications after Hodgkin’s disease. Ann Oncol 7(Suppl 4):115–126

    Article  PubMed  Google Scholar 

  14. Oerlemans S, Mols F, Nijziel MR et al (2011) The impact of treatment, socio-demographic and clinical characteristics on health-related quality of life among Hodgkin’s and non-Hodgkin’s lymphoma survivors: a systematic review. Ann Hematol 90:993–1004

    Article  PubMed  Google Scholar 

  15. Den Oudsten BL, Van Heck GL, De VJ (2007) The suitability of patient-based measures in the field of Parkinson’s disease: a systematic review. Mov Disord 22:1390–1401

    Article  Google Scholar 

  16. Mols F, Vingerhoets AJ, Coebergh JW et al (2005) Quality of life among long-term breast cancer survivors: a systematic review. Eur J Cancer 41:2613–2619

    Article  PubMed  Google Scholar 

  17. Cocks K, King MT, Velikova G et al (2011) Evidence-based guidelines for determination of sample size and interpretation of the European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire Core 30. J Clin Oncol 29:89–96

    Article  PubMed  Google Scholar 

  18. Ware JE, Kosinski M, Dewey J (2000) How to score version 2 of the SF-36 health survey. Quality Metric, Lincoln

    Google Scholar 

  19. Norman GR, Sloan JA, Wyrwich KW (2003) Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. Med Care 41:582–592

    PubMed  Google Scholar 

  20. Hjermstad MJ, Fossa SD, Oldervoll L et al (2005) Fatigue in long-term Hodgkin’s disease survivors: a follow-up study. J Clin Oncol 23:6587–6595

    Article  PubMed  Google Scholar 

  21. Ng AK, Li S, Recklitis C et al (2005) A comparison between long-term survivors of Hodgkin’s disease and their siblings on fatigue level and factors predicting for increased fatigue. Ann Oncol 16:1949–1955

    Article  PubMed  CAS  Google Scholar 

  22. Ruffer JU, Flechtner H, Tralls P et al (2003) Fatigue in long-term survivors of Hodgkin’s lymphoma; a report from the German Hodgkin Lymphoma Study Group (GHSG). Eur J Cancer 39:2179–2186

    Article  PubMed  CAS  Google Scholar 

  23. Loge JH, Abrahamsen AF, Ekeberg O et al (1999) Hodgkin’s disease survivors more fatigued than the general population. J Clin Oncol 17:253–261

    PubMed  CAS  Google Scholar 

  24. Loge JH, Abrahamsen AF, Ekeberg O et al (2000) Fatigue and psychiatric morbidity among Hodgkin’s disease survivors. J Pain Symptom Manag 19:91–99

    Article  CAS  Google Scholar 

  25. Knobel H, Loge JH, Lund MB et al (2001) Late medical complications disease and fatigue in Hodgkin’s disease survivors. J Clin Oncol 19:3226–3233

    PubMed  CAS  Google Scholar 

  26. Khimani N, Chen YH, Mauch PM et al (2013) Influence of new late effects on quality of life over time in Hodgkin lymphoma survivors: a longitudinal survey study. Ann Oncol 24:226–230

    Article  PubMed  CAS  Google Scholar 

  27. Hjermstad MJ, Oldervoll L, Fossa SD et al (2006) Quality of life in long-term Hodgkin’s disease survivors with chronic fatigue. Eur J Cancer 42:327–333

    Article  PubMed  Google Scholar 

  28. Loge JH, Abrahamsen AF, Ekeberg O et al (1999) Reduced health-related quality of life among Hodgkin’s disease survivors: a comparative study with general population norms. Ann Oncol 10:71–77

    Article  PubMed  CAS  Google Scholar 

  29. Mols F, Vingerhoets AJJM, Coebergh JW et al (2006) Better quality of life among 10–15 year survivors of Hodgkin’s lymphoma compared to 5–9 year survivors: a population-based study. Eur J Cancer 42:2794–2801

    Article  PubMed  Google Scholar 

  30. Wettergren L, Björkholm M, Axdorph U et al (2004) Determinants of health-related quality of life in long-term survivors of Hodgkin’s lymphoma. Quality of Life Research. An Int J Qual Life Aspects of Treat Care & Rehabil 13:1369–1379

    Article  CAS  Google Scholar 

  31. Oldervoll LM, Loge JH, Kaasa S et al (2007) Physical activity in Hodgkin’s lymphoma survivors with and without chronic fatigue compared with the general population—a cross-sectional study. BMC Cancer 7:210

    Article  PubMed  Google Scholar 

  32. Joly F, HenryAmar M, Arveux P et al (1996) Late psychosocial sequelae in Hodgkin’s disease survivors: a French population-based case–control study. J Clin Oncol 14:2444–2453

    PubMed  CAS  Google Scholar 

  33. Gil-Fernandez JJ, Ramos C, Tamayo AT et al (2003) Quality of life and psychological well-being in Spanish long-term survivors of Hodgkin’s disease: results of a controlled pilot study. Ann Hematol 82:14–18

    PubMed  CAS  Google Scholar 

  34. van Tulder MW, Aaronson NK, Bruning PF (1994) The quality of life of long-term survivors of Hodgkin’s disease. Ann Oncol 5:153–158

    PubMed  Google Scholar 

  35. Brandt J, Dietrich S, Meissner J et al (2010) Quality of life of long-term survivors with Hodgkin lymphoma after high-dose chemotherapy, autologous stem cell transplantation, and conventional chemotherapy. Leuk Lymphoma 51:2012–2020

    Article  PubMed  CAS  Google Scholar 

  36. Greil R, Holzner B, Kemmler G et al (1999) Retrospective assessment of quality of life and treatment outcome in patients with Hodgkin’s disease from 1969 to 1994. Eur J Cancer 35:698–706

    Article  PubMed  CAS  Google Scholar 

  37. Heutte N, Flechtner HH, Mounier N et al (2009) Quality of life after successful treatment of early-stage Hodgkin’s lymphoma: 10-year follow-up of the EORTC-GELA H8 randomised controlled trial. Lancet Oncol 10:1160–1170

    Article  PubMed  Google Scholar 

  38. Miltenyi Z, Magyari F, Simon Z et al (2010) Quality of life and fatigue in Hodgkin’s lymphoma patients. Tumori 96:594–600

    PubMed  Google Scholar 

  39. Norum J, Wist EA (1996) Quality of life in survivors of Hodgkin’s disease. Qual Life Res 5:367–374

    Article  PubMed  CAS  Google Scholar 

  40. Chalder T, Berelowitz G, Pawlikowska T et al (1993) Development of a fatigue scale. J Psychosom Res 37:147–153

    Article  PubMed  CAS  Google Scholar 

  41. Smets EM, Garssen B, Bonke B et al (1995) The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue. J Psychosom Res 39:315–325

    Article  PubMed  CAS  Google Scholar 

  42. Ware JE Jr, Sherbourne CD (1992) The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 30:473–483

    Article  PubMed  Google Scholar 

  43. Aaronson NK, Ahmedzai S, Bergman B et al (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85:365–376

    Article  PubMed  CAS  Google Scholar 

  44. Nyenhuis DL, Yamamoto C, Luchetta T et al (1999) Adult and geriatric normative data and validation of the profile of mood states. J Clin Psychol 55:79–86

    Article  PubMed  CAS  Google Scholar 

  45. Abernethy AP, Zafar SY, Uronis H et al (2010) Validation of the Patient Care Monitor (Version 2.0): a review of system assessment instrument for cancer patients. J Pain Symptom Manage 40:545–558

    Article  PubMed  Google Scholar 

  46. Browne JP, O’Boyle CA, McGee HM et al (1997) Development of a direct weighting procedure for quality of life domains. Qual Life Res 6:301–309

    Article  PubMed  CAS  Google Scholar 

  47. Loge JH, Ekeberg O, Kaasa S (1998) Fatigue in the general Norwegian population: normative data and associations. J Psychosom Res 45:53–65

    Article  PubMed  CAS  Google Scholar 

Download references

Disclosure

The authors have declared no conflicts of interest.

Author information

Authors and Affiliations

  1. Departments of Clinical Oncology, K1-P, Leiden University Medical Center, Albinusdreef 2, P.O. Box 9600, 2300 RC, Leiden, The Netherlands

    Laurien A. Daniëls, Augustinus D. G. Krol & Carien L. Creutzberg

  2. Comprehensive Cancer Centre South, Eindhoven, The Netherlands

    Simone Oerlemans & Lonneke V. van de Poll-Franse

  3. Center of Research on Psychology in Somatic Diseases (CoRPS), Tilburg University, Tilburg, The Netherlands

    Simone Oerlemans & Lonneke V. van de Poll-Franse

Authors
  1. Laurien A. Daniëls
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Simone Oerlemans
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Augustinus D. G. Krol
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Lonneke V. van de Poll-Franse
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Carien L. Creutzberg
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Laurien A. Daniëls.

Electronic supplementary material

Below is the link to the electronic supplementary material.

ESM 1

(DOC 241 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Daniëls, L.A., Oerlemans, S., Krol, A.D.G. et al. Persisting fatigue in Hodgkin lymphoma survivors: a systematic review. Ann Hematol 92, 1023–1032 (2013). https://doi.org/10.1007/s00277-013-1793-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-013-1793-2

Keywords

Search

Navigation